[go: up one dir, main page]

FI20080333A0 - Influenza virus nucleic acids and peptides - Google Patents

Influenza virus nucleic acids and peptides

Info

Publication number
FI20080333A0
FI20080333A0 FI20080333A FI20080333A FI20080333A0 FI 20080333 A0 FI20080333 A0 FI 20080333A0 FI 20080333 A FI20080333 A FI 20080333A FI 20080333 A FI20080333 A FI 20080333A FI 20080333 A0 FI20080333 A0 FI 20080333A0
Authority
FI
Finland
Prior art keywords
peptides
nucleic acids
influenza virus
virus nucleic
influenza
Prior art date
Application number
FI20080333A
Other languages
Finnish (fi)
Swedish (sv)
Inventor
Jari Natunen
Jukka Hiltunen
Ritva Niemelae
Jari Helin
Olli Aitio
Original Assignee
Glykos Finland Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glykos Finland Oy filed Critical Glykos Finland Oy
Priority to FI20080333A priority Critical patent/FI20080333A0/en
Publication of FI20080333A0 publication Critical patent/FI20080333A0/en
Priority to PCT/FI2009/050357 priority patent/WO2009133249A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6081—Albumin; Keyhole limpet haemocyanin [KLH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16211—Influenzavirus B, i.e. influenza B virus
    • C12N2760/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16211—Influenzavirus B, i.e. influenza B virus
    • C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
FI20080333A 2008-05-02 2008-05-02 Influenza virus nucleic acids and peptides FI20080333A0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FI20080333A FI20080333A0 (en) 2008-05-02 2008-05-02 Influenza virus nucleic acids and peptides
PCT/FI2009/050357 WO2009133249A1 (en) 2008-05-02 2009-05-04 Peptide vaccine for influenza virus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20080333A FI20080333A0 (en) 2008-05-02 2008-05-02 Influenza virus nucleic acids and peptides

Publications (1)

Publication Number Publication Date
FI20080333A0 true FI20080333A0 (en) 2008-05-02

Family

ID=39523003

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20080333A FI20080333A0 (en) 2008-05-02 2008-05-02 Influenza virus nucleic acids and peptides

Country Status (2)

Country Link
FI (1) FI20080333A0 (en)
WO (1) WO2009133249A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104220091A (en) * 2012-02-14 2014-12-17 科学与工业研究会 Synthetic peptides capable of binding to influenza hemagglutinin protein
US9969794B2 (en) 2012-05-10 2018-05-15 Visterra, Inc. HA binding agents
EP3374390A1 (en) 2015-11-13 2018-09-19 Visterra, Inc. Compositions and methods for treating and preventing influenza
WO2017147248A1 (en) 2016-02-24 2017-08-31 Visterra, Inc. Formulations of antibody molecules to influenza virus
WO2018013704A1 (en) 2016-07-12 2018-01-18 Duke University Engineered influenza polynucleotides, viruses, vaccines and methods of making and using the same
US12419946B2 (en) 2019-02-07 2025-09-23 Duke University Stabilized 9 and 10 segmented influenza viruses as a vaccine platform and methods of making and using same
WO2020198329A1 (en) 2019-03-25 2020-10-01 Visterra, Inc. Compositions and methods for treating and preventing influenza
WO2021184062A1 (en) * 2020-03-16 2021-09-23 Lateral IP Pty Ltd Compositions for treating respiratory tract infection and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7118874B2 (en) * 1998-10-09 2006-10-10 Variation Biotechnologies Inc. Immunogenic formulation and process for preparation thereof
FI20060200A0 (en) * 2005-04-20 2006-02-27 Glykos Finland Oy Method for analyzing the specificity of sialic acid binding of human influenza virus
MX2007015105A (en) * 2005-06-01 2008-03-18 Variation Biotechnologies Inc Peptide-based influenza vaccine formulation.
EP2069376A4 (en) * 2006-07-21 2013-10-16 Pharmexa Inc Inducing cellular immune responses to influenza virus using peptide and nucleic acid compositions
FI20060946A0 (en) * 2006-10-26 2006-10-26 Glykos Finland Oy Influenza virus nucleic acids and peptides

Also Published As

Publication number Publication date
WO2009133249A1 (en) 2009-11-05

Similar Documents

Publication Publication Date Title
DK2245027T3 (en) Hepatitis C virus inhibitors
BRPI0907733A2 (en) Hepatitis C virus inhibitors
BRPI0915487A2 (en) nfluenza hemagglutin and neuraminidase variants
IL239023A0 (en) Neutralizing antibodies to influenza virus
DK2478916T3 (en) Influenza vaccines containing hemagglutinin and matrix proteins
BRPI0915142A2 (en) polypeptides, nucleic acid and uses thereof
BRPI0821034A2 (en) Modified Influenza Virus
BRPI0912198A2 (en) anti-fn14 antibodies and uses thereof
BRPI0922790A2 (en) sparc-binding peptides and uses thereof
CY2015012I2 (en) HEPATITIS C VIRUS INHIBITORS
DK2242752T3 (en) Imidazolyl-biphenylimidazoles as hepatitis C virus inhibitors
FI20060946A0 (en) Influenza virus nucleic acids and peptides
EP2207899A4 (en) ASSEMBLE OF LARGE NUCLEIC ACIDS
BRPI1007836A2 (en) Hepatitis C Virus Inhibitors
IL213189A0 (en) Recombinant avian influenza vaccine and uses thereof
DK2049559T3 (en) Improved HPV vaccines
CR10571A (en) RECOMBINING VIRIC VACCINE
FI20080333A0 (en) Influenza virus nucleic acids and peptides
EP2118323A4 (en) Detection of influenza virus
BR112012004731A2 (en) wnt10-derived peptides and their use
ZA200809056B (en) Influenza virus vaccine
FI20090030A0 (en) Oncolytic virus
DK2043682T3 (en) INFLUENZA VACCINE
EP2486054A4 (en) RECOMBINANT ANTIBODIES TO H1N1 INFLUENZA
BRPI0923034A2 (en) hepatitis c virus combination therapy